Hikma Pharmaceuticals in den Nachrichten
Hochwertige, zugängliche Medikamente
Tamtam hat 13 aktuelle Artikel über Hikma Pharmaceuticals gefunden.
- Hikma stock heads into the open after a modest gain
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
- Hikma Pharmaceuticals climbs Friday, outperforms market
- A needle-free epinephrine spray is under review in the US, Europe and UK
- Hikma advances its epinephrine nasal spray with multi-market regulatory filings
- Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets
- ii view: Hikma keeps a healthy pulse with solid first half
- Hikma Pharmaceuticals rallies on improving trends
- Hikma Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data
- Rep. Cockley Applauds Hikma Pharmaceuticals Expansion, Investment in Columbus Workforce | Republican News
- Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court (via Passle)
- Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
- Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Hikma Pharmaceuticals?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden